Shopping Cart
Remove All
Your shopping cart is currently empty
LSD1-IN-31 (compound 11e) interacts directly with the LSD1/CoREST complex, inhibiting the demethylase activity of LSD1. This inhibition of LSD1 demethylase activity impacts the downstream IκB/NF-κB signaling pathway. Furthermore, LSD1-IN-31 can inhibit osteoclast-mediated bone loss both in vitro and in vivo. This compound is utilized in research on osteoporosis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | LSD1-IN-31 (compound 11e) interacts directly with the LSD1/CoREST complex, inhibiting the demethylase activity of LSD1. This inhibition of LSD1 demethylase activity impacts the downstream IκB/NF-κB signaling pathway. Furthermore, LSD1-IN-31 can inhibit osteoclast-mediated bone loss both in vitro and in vivo. This compound is utilized in research on osteoporosis. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.